HR 3566, the ANCHOR for Military Families Act, requires the Department of Defense to provide military members and their families with comprehensive relocation assistance information at least 45 days before a permanent change of station. The bill mandates that this information cover educational resources for children (including school transitions, special education, and Individualized Education Programs), housing options, mental health support, spouse employment assistance, and legal/financial counseling. It directs the Secretary of Defense to integrate these details into accessible briefings, online resources, and materials at military installations. The law also requires annual reports to Congress on implementation progress and family awareness of available support programs. This bill directly affects active-duty service members and their families facing relocation due to military orders.
The ETHIC Act (HR 3269) limits how many patents pharmaceutical companies can assert in lawsuits against generic drug and biosimilar manufacturers. Specifically, it prohibits a company from claiming more than one patent per "Patent Group" (commonly owned patents linked through disclaimers) in an infringement case involving a generic drug applicant or biosimilar product. This directly affects generic drug makers (under FDA's 505(b)(2) or 505(j) pathways) and biosimilar developers (under the Public Health Service Act), reducing the ability of brand-name companies to use stacked patents to delay competition. The law applies to applications submitted after its enactment date.
Fentanyl Awareness for Children and Teens in Schools Act or the FACTS Act This bill establishes grant programs and requires strategies and studies to address the misuse of synthetic opioids (i.e., laboratory-derived substances such as fentanyl and its derivatives) among youth. The bill requires the Department of Health and Human Services (HHS) to award grants to partnerships between educational and health organizations for prevention, treatment, and recovery efforts related to the use of synthetic opioids by middle and high school-aged children. It also allows school-based health centers to use existing HHS grants to purchase naloxone to reverse the effects of opioid overdoses and to establish programs to address misuse of synthetic opioids. Also, the bill authorizes state educational agencies to use certain Department of Education (ED) grant funds to provide training to school personnel on addressing students’ misuse of synthetic opioids. State and local educational agencies must also address such misuse in their educational plans in order to qualify for certain ED grants. Finally, the bill (1) establishes an interagency taskforce to coordinate federal efforts to address synthetic opioid misuse among youth, (2) requires an evaluation of the State Unintentional Drug Overdose Reporting System’s effectiveness in identifying the specific synthetic opioids causing youth overdoses, (3) expands the data reported by the National Center for Education Statistics to include information about the use of synthetic opioids in schools, and (4) requires two recurring HHS surveys to include questions on youth exposure to synthetic opioids.
This bill extends the temporary waiver allowing hospitals to provide acute care at home until 2030, directly affecting hospitals participating in the Acute Hospital Care at Home initiative and the patients receiving care through this program. It requires the Department of Health and Human Services to conduct a detailed study by September 2028, comparing care quality, costs, patient outcomes, and experiences between home-based care and traditional inpatient hospital care. The study must analyze specific metrics like readmission rates, staffing ratios, treatment types, and patient demographics across participating and non-participating hospitals. The findings will be reported to Congress, providing data to inform future policy decisions about home-based hospital care.
HR 2793, the Retirement Freedom Act, allows Medicare Part A beneficiaries to voluntarily opt out of the program. Individuals who choose to opt out can later rejoin Medicare Part A without penalty or additional requirements, and they will not be required to give up Social Security benefits (Title II) to make this choice. The bill also ensures beneficiaries won't have to repay Medicare Part A payments received before opting out. This change directly affects current Medicare Part A enrollees who wish to explore alternative health coverage options.
Rural Telehealth and Education Enhancement Act of 2025 This bill reauthorizes the Distance Learning and Telemedicine Program through FY2030. This Department of Agriculture program provides grants to help rural communities gain the technology and training necessary to engage in telemedicine and distance learning.
This bill would expand Department of Veterans Affairs benefits to cover children of male Vietnam veterans with birth defects related to Agent Orange exposure, currently only covering spina bifida. It would establish health assessment programs and treatment centers for Vietnamese Americans affected by Agent Orange and their descendants. The bill also requires research into intergenerational health effects and mandates implementation within 18 months of enactment. It would extend recognition to include Vietnamese, Lao, and Cambodian people affected by Agent Orange exposure during the Vietnam War.
HR 2943, the Gabriel Rosenberg Dyspraxia/DCD Coverage Act, requires the U.S. Comptroller General to study insurance coverage for dyspraxia/developmental coordination disorder (DCD), a condition affecting movement and coordination. The study, to be completed within one year of enactment, will examine coverage under Medicare, Medicaid, group health plans, and other federal health programs across all states. It will specifically investigate current coverage availability, age limits, barriers like provider shortages, compliance with existing insurance rules, and whether adults lose coverage after diagnosis. The resulting report will provide recommendations for improving coverage, but the bill itself does not change insurance requirements or create new benefits. This is a procedural study bill focused on gathering data about current coverage gaps for people with DCD.
HR 5278, the Affordable Inhalers and Nebulizers Act of 2025, limits out-of-pocket costs for patients using prescription inhalers and nebulizers to treat asthma and chronic obstructive pulmonary disease (COPD). The bill requires private health insurance plans, Medicare Part B and Part D, and new payment programs to cover these products with no deductible and a maximum cost of $15 per 30-day supply. It directly affects patients with asthma or COPD who rely on covered inhalers, nebulizers, and related equipment like spacers. The law applies to all specified inhaler products (including medications and administration equipment) and takes effect for plan years beginning January 1, 2026.
The Autism Family Caregivers Act of 2025 creates a 5-year pilot program funding grants to community organizations for free, evidence-based skills training for family caregivers of children (ages 0-9) with autism spectrum disorder or other developmental disabilities or delays. The program requires training in communication, social engagement, daily living skills, and caregiver self-care strategies, with emphasis on cultural competence and coordination with local health, education, and community services. Grants must support at least 25 organizations across 15+ states, using $10 million annually (2026-2030), and mandate stakeholder committees including caregivers and local providers. It directly affects families caring for young children with these conditions by expanding access to structured support, while requiring programs to supplement - rather than replace - existing Medicaid, education, or insurance-covered services.
